Samsung Bioepis Announces 24-week Interim Results from a Phase 3 Trial of SB11, Proposed Ranibizumab Biosimilar

In a Phase 3 study, SB11 demonstrated equivalent efficacy in terms of change in best…

ENHERTU® Granted Breakthrough Therapy Designation in the U.S. for HER2 Mutant Metastatic Non-Small Cell Lung Cancer

Designation based on phase 2 DESTINY-Lung01 This is the third Breakthrough Therapy Designation for ENHERTU,…

Accenture Acquires Byte Prophecy to Enhance AI and Digital Analytics Capabilities in Emerging Markets

Acquisition to improve speed and agility of delivering advanced analytics, data and AI solutions to…

AHF to World Health Assembly: Put Lives Before Politics and Ensure Transparency and Accountability for Global Public Health!

AHF urges the World Health Assembly at its virtual summit starting May 18 to put…

SolarWinds Expands Partnership With M.Tech to Help Technology Professionals Solve Today’s IT Challenges in China

SINGAPORE--(BUSINESS WIRE)--SolarWinds (NYSE: SWI), a leading provider of powerful and affordable IT management software, has…

Citi Hong Kong Releases Results of First Quarter 2020 Residential Property Ownership Survey

10% of respondents believe now is a good time to buy property, the highest percentage…

Mitsubishi Electric Begins Demonstrating Local 5G System in Japan

Aiming at new 5G services, such as one-stop solutions via local 5G systems TOKYO--(BUSINESS WIRE)--Mitsubishi…

Boutir and iClick form Strategic Partnership

Boutir benefits from iClick's 900+ million Chinese consumers' datasetsIncreases the technological sophistication of Boutir's ad…

Trading Technologies and Zhengzhou Esunny Information Technology Partner to Provide Connectivity to Chinese Derivatives Markets

CHICAGO & ZHENGZHOU CITY, China--(BUSINESS WIRE)--Trading Technologies International, Inc. (TT), a global provider of high-performance…